X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

Sanofi Sets Up Fund To Enable Firms In Low-Income Countries

Content Team by Content Team
5th July 2022
in Manufacturing, Middle East and South Asia, News
Dupixent From Sanofi Delivers Another Fantastic Performance

The Paris-based pharmaceutical company is setting up a fund to assist companies who want to provide healthcare solutions in neglected areas. The objective is to assist in the establishment of locally resilient organisations.

According to Jon Fairest of Sanofi, innovation from his expertise on the African continent and the digitization of new enterprises is very spectacular. However, they may not receive the financing and investment that they do in the more developed world because they may not have the visibility that they do.

Fairest, who oversaw Sanofi’s operations in Africa for six of his 20+ years there, now serves as the unit’s leader for global health. The non-profit organisation was founded in April of last year with the goal of distributing medications and supporting healthcare systems in underdeveloped nations. Sanofi offers 40 underdeveloped countries throughout the world 30 of its medications at no cost. The World Health Organization has classified all of the treatments as essential medications. They cover a wide range of therapeutic areas, but Sanofi lays particular focus on goods for diabetes, cancer, and tuberculosis.

In terms of the number of people with cardio/metabolic diseases in these nations, it’s often a pandemic in itself, according to Fairest. No one has received training on even how to manage it. They are truly leaving a legacy in terms of general healthcare when they enter a country and are successful with a programme.

Sanofi announced recently that it is introducing an Impact brand to further distinguish its not-for-profit products. According to Fairest, the initiative will aid in increasing the effectiveness and efficiency of the 30 different medications’ delivery.

The host countries must be committed to giving the Impact project a chance to succeed. Sanofi travels to choose which countries to start in, most recently to Rwanda. According to Fairest, it will be simpler to introduce Impact to adjacent nations once success has been established. The Sanofi project has so far reached about 150,000 patients. The only way the business can achieve its future goal of making millions is by creating processes that are scalable and self-sustaining.

They won’t continue to invest indefinitely. Fairest added that they would anticipate them carrying this forward once they construct the model and feel that people are benefiting. They desire knowledge. Starting with a few target nations, they will consider the next steps before moving on.

Previous Post

Singapore Authorises New Ovarian Cancer Treatment By GSK

Next Post

Deloitte Believes Mature R&D Firms Reap Enterprise Value

Related Posts

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Drugs Gain From Tardigrade Proteins, Says Research
Drug Development

Pharma Drugs Gain From Tardigrade Proteins, Says Research

22nd March 2023
Next Post
Deloitte Believes Mature R&D Firms Reap Enterprise Value

Deloitte Believes Mature R&D Firms Reap Enterprise Value

Latest News

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In